Randomized, Double-Blind, Placebo-Controlled Study of Nitazoxanide in the Treatment of Chronic Hepatitis C

Trial Profile

Randomized, Double-Blind, Placebo-Controlled Study of Nitazoxanide in the Treatment of Chronic Hepatitis C

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Oct 2008

At a glance

  • Drugs Nitazoxanide (Primary)
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Sponsors Romark Laboratories
  • Most Recent Events

    • 22 Oct 2008 Last checked against ClinicalTrials.gov record.
    • 01 Sep 2008 Secondary endpoint 'Viral load' has been met.
    • 01 Sep 2008 Secondary endpoint 'Sustained virological response rate' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top